Sanford C. Bernstein Lowers Centene (NYSE:CNC) Price Target to $88.00

Centene (NYSE:CNC) had its price target lowered by equities researchers at Sanford C. Bernstein from $96.00 to $88.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Sanford C. Bernstein’s price target would suggest a potential upside of 41.34% from the company’s current price.

Other equities analysts have also recently issued reports about the company. Robert W. Baird dropped their price objective on Centene from $83.00 to $66.00 and set a “neutral” rating for the company in a report on Friday, October 25th. TD Cowen lifted their price objective on Centene from $80.00 to $89.00 and gave the company a “buy” rating in a report on Wednesday, July 31st. Truist Financial dropped their price objective on Centene from $92.00 to $89.00 and set a “buy” rating for the company in a report on Monday, July 15th. Oppenheimer lowered their price target on Centene from $110.00 to $95.00 and set an “outperform” rating for the company in a report on Monday, July 29th. Finally, Wells Fargo & Company lowered their price target on Centene from $93.00 to $91.00 and set an “overweight” rating for the company in a report on Friday, September 13th. Seven investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $84.00.

Centene Stock Up 0.8 %

CNC stock opened at $62.26 on Wednesday. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.64. The business has a 50 day moving average price of $71.55 and a two-hundred day moving average price of $72.02. The company has a market cap of $32.75 billion, a price-to-earnings ratio of 10.81, a P/E/G ratio of 0.98 and a beta of 0.48. Centene has a twelve month low of $59.77 and a twelve month high of $81.42.

Institutional Trading of Centene

Several institutional investors have recently added to or reduced their stakes in CNC. EP Wealth Advisors LLC lifted its holdings in shares of Centene by 1.0% during the 1st quarter. EP Wealth Advisors LLC now owns 13,604 shares of the company’s stock valued at $1,068,000 after buying an additional 133 shares during the period. WR Wealth Planners LLC grew its position in shares of Centene by 41.4% during the second quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock valued at $31,000 after purchasing an additional 137 shares in the last quarter. Whittier Trust Co. grew its position in Centene by 10.0% in the second quarter. Whittier Trust Co. now owns 1,562 shares of the company’s stock worth $104,000 after acquiring an additional 142 shares in the last quarter. Fidelis Capital Partners LLC lifted its stake in Centene by 5.0% in the first quarter. Fidelis Capital Partners LLC now owns 3,316 shares of the company’s stock worth $260,000 after purchasing an additional 158 shares during the last quarter. Finally, Mount Yale Investment Advisors LLC lifted its stake in Centene by 2.1% in the third quarter. Mount Yale Investment Advisors LLC now owns 8,082 shares of the company’s stock worth $608,000 after purchasing an additional 167 shares during the last quarter. 93.63% of the stock is currently owned by hedge funds and other institutional investors.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.